Cargando…
Optimizing Blood Stem Cell Transplants Through Cellular Engineering
Haematopoietic stem cell transplants (HSCT) are used in the treatment of blood cancers, autoimmune diseases, and metabolic disorders. Over 1.5 million transplants have been performed around the world thus far. In an attempt to enhance the efficacy of the cells used for transplantation, efforts are u...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Asia-Pacific Blood and Marrow Transplantation Group
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847292/ https://www.ncbi.nlm.nih.gov/pubmed/36714264 http://dx.doi.org/10.31547/bct-2021-008 |